Status:
COMPLETED
TELEMEDICINE,Maintenance of a Respiratory Rehabilitation Program in Patients With Chronic Obstructive Pulmonary Disease.
Lead Sponsor:
JUAN B GALDIZ ITURRI
Collaborating Sponsors:
Instituto de Salud Carlos III
Hospital de Cruces
Conditions:
COPD
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Respiratory rehabilitation (RR) has been shown to provide benefits in patients with Chronic Obstructive Pulmonary Disease (COPD) with a degree of evidence A. These benefits are primarily focused on a...
Detailed Description
1. SELECTION AND WITHDRAWAL OF SUBJECTS 1.1 INCLUSION CRITERIA To be eligible to participate in this study, subjects must meet the following inclusion criteria: Patients diagnosed with COP...
Eligibility Criteria
Inclusion
- patients with COPD
- age 8 and 75 (both included)
- index BODE's 3-7 ( BODE Iindex for Body-mass index, airflow Obstruction, Dyspnea, and Exercise)
- clinical stability, understood as not having an exacerbation (\*) of the COPD and do not require treatment with antibiotics, corticoids systemic and/or hospitalization, at least in the 30 days prior to their inclusion
- has given his consent
- capable of using technology
- the subject is willing and is able to meet all the requirements of the study. \* Exacerbation : Exacerbation means worsening of two or more of the following main symptoms for at least 2 consecutive days: dyspnea, volume of sputum; Sputum purulence o worsening of any main symptom along with one of the following symptoms for at least 2 consecutive days: sore throat; Cold ( nasal congestion); Fever without any other cause; Cough; Wheezing
Exclusion
- Osteo-muscular pathology that limit or preclude the exercises
- Presence of heart disease which limit exercise program
- patients with bronchiectasis or other several of COPD respiratory disorders
- comorbidity that prevent respiratory rehabilitation of maintenance program
- less than 2 years life expectancy
- any unstable medical or psychiatric process or substance abuse which, in the opinion of the investigator, would affect the ability of the patient to complete the study or impede their participation in the study
Key Trial Info
Start Date :
October 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 24 2017
Estimated Enrollment :
94 Patients enrolled
Trial Details
Trial ID
NCT03247933
Start Date
October 1 2014
End Date
February 24 2017
Last Update
August 30 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cruces University Hospital, Biocruces Institute
Barakaldo, Bizkaia, Spain, 48903